Morgagni Hernia Repair in Adults: A Single-Center Experience in Spanish Population.

Introduction: Morgagni hernia (MH) is a rare congenital disorder, especially in adults, accounting for 2%-4% of all congenital diaphragmatic hernias. Materials and Methods: Retrospective review of all patients who underwent surgical repair of MH at our center from 1991 to 2022. A descriptive analysis was performed. Results: Eighteen patients presented with MH, of whom 11 (61.11%) were female, with a median age of 67.60 (IQR 50.25-84.50) years old. Six (33.33%) were asymptomatic and 12 (66.67%) presented with symptoms, being dyspnea (4; 33.33%) the most common. On the group of symptomatic patients, the computed tomography scan (8; 66.67%) was the most frequent diagnostic test. Whereas in the asymptomatic group, 5 patients (83.33%) were diagnosed intraoperatively, during surgery for other reasons. MH was mostly located on the right (16; 88.89%). Hernia contents included omentum and colon (10; 55.56%), omentum (5; 27.78%), and stomach (3; 16.67%). All patients underwent surgical repair, needing in 3 cases (16.67%) emergency surgery. Surgical approaches included 10 laparoscopies (55.56%), 7 laparotomies (38.89%), and 1 thoracotomy (5.55%). Repair was generally performed whether by primary closure in 8 patients (44.4%) or by mesh implantation in 10 (55.56%). The median hospital stay was 6 days (IQR 3-10). Three patients presented complications (17.65%): urinary tract infection (1 patient), intra-abdominal collection (1 patient), and the last 1 presented with renal failure and pneumonia. The median follow-up was 74 months (IQR 4.5-130). No recurrence was described. Conclusions: MH is a rare condition in the adult population. In our series most patients presented with symptoms. The gold standard treatment is surgical repair, being the laparoscopic approach the most frequent. The complications rate was relatively low and no recurrence was described in our study.

Experiencia inicial del tratamiento de la carcinomatosis peritoneal irresecable con PIPAC / Initial Single-center Experience of PIPAC in Patients With Unresectable Peritoneal Metastasis

Introducción: La carcinomatosis peritoneal se asocia a un mal pronóstico y las opciones terapéuticas son limitadas. El desarrollo de la quimioterapia intraperitoneal presurizada en aerosol (PIPAC) ofrece una alternativa de tratamiento paliativo para estos pacientes con una baja tasa de morbimortalidad. Nuestro objetivo es evaluar la implantación y la experiencia inicial de PIPAC para el tratamiento de la carcinomatosis peritoneal irresecable en nuestro centro. Material y métodos: Realizamos un estudio prospectivo incluyendo todos los pacientes a los que se les realizó PIPAC entre enero de 2019 y febrero de 2020 en nuestro hospital. Se recogieron: el origen del tumor primario, el volumen de ascitis, la extensión de la carcinomatosis peritoneal, el régimen de quimioterapia aplicada, el tiempo quirúrgico, las complicaciones postoperatorias, la estancia hospitalaria y la mortalidad. Resultados: Analizamos 9 PIPAC realizadas en 5pacientes con carcinomatosis peritoneal de origen gástrico, ovárico y neoplasia mucinosa apendicular. La tasa de acceso a la cavidad peritoneal fue del 100%. El PCI medio fue 27,6 (24-35). El tiempo quirúrgico medio fue de 93min (70-125). En nuestra serie solo hubo una complicación Clavien-DindoII (1/9 procedimientos). La estancia hospitalaria media fue de 2días (1-4). La mortalidad fue del 0%. Conclusión: La implantación de PIPAC en nuestro centro se ha llevado a cabo con seguridad, pudiendo afirmar que es una técnica reproducible y con una baja tasa de morbimortalidad en nuestra experiencia inicial. (AU)

Introduction: Peritoneal carcinomatosis remains a condition with poor prognosis and limited therapeutic options. Pressurized Intrapertioneal Aerosol Chemotherapy (PIPAC) has been developed as a new tool for delivering intraperitoneal chemotherapy with low morbidity. The aim of this study was to evaluate the initial experience of PIPAC in patients with peritoneal carcinomatosis at our hospital. Methods: A prospective study between January 2019 and February 2020 was carried at a tertiary public hospital. Primary tumor, ascites volume, PCI, chemotherapy regimen, operative time, morbidity, length of hospital stay and mortality were recorded for analysis. Results: We analyzed 9 PIPAC procedures performed in 5patients. Median PCI was 27.6 (24-35). Median surgical time was 93minutes (70-125). Only one adverse event occurred out of 9 procedures (Clavien-DindoII). Median length of hospital stay was 2days (1-4). Mortality was 0%. Conclusion: PIPAC seems to be a feasible and safe procedure to treat peritoneal carcinomatosis, with low morbidity and short hospital stay. (AU)

Initial Single-center Experience of PIPAC in Patients With Unresectable Peritoneal Metastasis. / Experiencia inicial del tratamiento de la carcinomatosis peritoneal irresecable con PIPAC.

INTRODUCTION: Peritoneal carcinomatosis remains a condition with poor prognosis and limited therapeutic options. Pressurized Intrapertioneal Aerosol Chemotherapy (PIPAC) has been developed as a new tool for delivering intraperitoneal chemotherapy with low morbidity. The aim of this study was to evaluate the initial experience of PIPAC in patients with peritoneal carcinomatosis at our hospital. METHODS: A prospective study between January 2019 and February 2020 was carried at a tertiary public hospital. Primary tumor, ascites volume, PCI, chemotherapy regimen, operative time, morbidity, length of hospital stay and mortality were recorded for analysis. RESULTS: We analyzed 9 PIPAC procedures performed in 5patients. Median PCI was 27.6 (24-35). Median surgical time was 93minutes (70-125). Only one adverse event occurred out of 9 procedures (Clavien-DindoII). Median length of hospital stay was 2days (1-4). Mortality was 0%. CONCLUSION: PIPAC seems to be a feasible and safe procedure to treat peritoneal carcinomatosis, with low morbidity and short hospital stay.

Duodenoyeyunostomía laparoscópica como tratamiento del síndrome de Wilkie. Análisis de una serie de cuatro casos / Laparoscopic duodenojejunostomy as a treatment for Wilkie's syndrome. Analysis of a four cases series

No disponible

Laparoscopic duodenojejunostomy as a treatment for Wilkie's syndrome. Analysis of a four cases series.

We present 4 cases of Wilkie's syndrome (WS) diagnosis in our Hospital between 2014-2019. WS is an infrequent disease, whose diagnosis can be challenging for patients suffering recurrent digestive symptoms. Our patients refered a history of chronic postprandial abdominal pain associated with vomiting, intestinal transit disorders or an uncontrolled weight loss. Abdominopelvic angio-CT was part of the research in all the cases, objectifying a decrease in the angle between Superior Mesenteric Artery (SAM) and Aorta below 25°. In case of chronic or refractory cases, the surgical treatment may be an option. Laparoscopic duodenojejunostomy constitutes the treatment of choice due its low rate of complications and acceptable results.

Management of Esophageal Perforation: 28-Year Experience in a Major Referral Center.

Esophageal perforation constitutes a surgical emergency. Despite its gravity, no single strategy has been described as sufficient to deal with most situations to date. The aim of this study was to assess the etiology, management, and outcome of esophageal perforation over a 28-year period, to characterize optimal treatment options in this severe disease. A retrospective clinical review of all patients treated for esophageal perforation at Ramón y Cajal Hospital between January 1987 and December 2015 was performed (n = 57). Iatrogenic injury was the most frequent cause of esophageal perforation (n = 32). Abdominal esophagus was the main location (23 patients; 40.4%). Eight patients (14%) were managed with antibiotics and parenteral nutrition. In seven patients (12.3%), an endoscopic stent was implanted. Surgical therapy was performed in 38 patients (66.7%). Morbidity and 90-day mortality rates were 61.4 and 28 per cent, respectively. Five patients were reoperated (8.8%). Median hospital stay was 23.5 days. The mortality rate was higher among patients with spontaneous and tumoral perforation (54.5 and 100%; P = 0.009), delayed diagnosis (>24 hours; P = 0.0001), and abdominal/thoracic location (37.5%; P = 0.05). No statistical differences were found between surgical and conservative/endoscopic management (31% vs 20%; P = 0.205) although hospital staying was longer in surgical group (36.30 days vs 15.63 days; P = 0.029). Esophageal perforation was associated with high morbidity and mortality rates. Global outcomes depend on etiology, site of perforation, and delay in diagnosis. An individualized approach for each patient should be chosen to prevent septic complications of this potentially fatal disease.

Neumotórax y síndrome de Marfan / Marfan syndrome and pneumothorax

No disponible

Abordaje laparoscópico de la oclusión intestinal / Laparoscopic approach to intestinal obstruction

No disponible

Short-term results for laparoscopic repair of large paraesophageal hiatal hernias with Gore Bio A® mesh.

BACKGROUND: The application of mesh-reinforced hiatal closure has resulted in a significant reduction in recurrence rates in comparison with primary suture repair. One of the most debated issues is the risk of complications related to the use of the prosthesis, such as esophageal erosion and postoperative dysphagia. The aim of this study is to present our short-terms results in the treatment of laparoscopic paraesophageal hiatal hernia (LPHH) with a synthetic polyglycolic acid:trimethylene carbonate mesh (Gore Bio A(®)). METHODS: From January 2011 to December 2012, 10 patients with large paraesophageal hiatal hernias and hiatal defect over 5 cm were included. Primary simple suture of the crura and additional reinforcement with a Gore Bio A(®) mesh was performed. Hiatal hernia or gastroesophageal reflux disease (GERD) symptoms recurrence, dysphagia and mesh-related complications were investigated. RESULTS: Of the 10 patients undergoing mesh repair, there were 7 women and 3 men with a mean age of 65.5 years. All operations were completed laparoscopically. Median postoperative stay was 3 days. After a median follow-up of 20.3 months, one patient developed a recurrent hiatal hernia (10%). There were no mesh-related complications. CONCLUSIONS: The use of Gore Bio A(®) mesh for the laparoscopic repair of large paraesophageal hiatal hernias is safe and with a reasonably low recurrence rate in this short-term study. Additional long-term studies with ample numbers carried out for years will be necessary to see if this synthetic mesh is not only safe but also successful in the prevention of recurrences.

Use of Foley's catheter to control port-site bleeding in bariatric surgery.

Abdominal wall bleeding in the port-site insertion placed during laparoscopic bariatric surgery is often difficult to control. From January 2005 to August 2011, 226 patients underwent bariatric surgery at our institutions. Seventeen patients (7.5%) presented port-site bleeding that could not be controlled with electrocautery and Foley's catheter (24 F) was used for bleeding inhibition. Of the 17 patients, there were 12 females (70.6%) and five males (29.4%) with a mean age of 38.35 years. Mean body mass index (BMI) was 44.2. Most of bleeding port-sites were located in hypochondrium and were 12-mm size. After the catheter removal (median 36 h), bleeding did not recur in any case. There were no other complications related to the port-side bleeding and the Foley catheter placement. Hospital stay was not prolonged due to the use of the Foley catheter. Port-site bleeding in bariatric surgery is a frequent complication. In up to 7.5% of the cases, the haemorrhage cannot be controlled with electrocautery. Compression with Foley catheter balloon is a safe and efficient method to stop bleeding.

[Use of Foley's catheter to control abdominal wall bleeding in the trocar insertion place during laparoscopic surgery]. / Uso de la sonda de Foley para el control del sangrado de la pared abdominal por los orifi cios de los trócares durante la cirugía laparoscópica.

BACKGROUND: Abdominal wall bleeding in the port-site insertion place during laparoscopic surgery is sometimes difficult to control and can be associated with morbidity ranging from parietal pain up to haematoma and massive haemoperitoneum. PATIENTS AND METHODS: We perform a retrospective study of our experience in the management of the abdominal wall bleeding port-site using a Foley's catheter (24F), in those cases when haemostasis with electrocautery was not achieved. RESULTS: This technique was used in 35 patients (27 women and 8 men) with a mean age of 45,37 years (range 24-82 years). The median of time up to the removal of the catheter was 36 hours (range 24-48 hours), without observing bleeding or prolongation of the hospital stay or readmission. CONCLUSIONS: The use of Foley's catheter is a simple and efficient method for the control of the port-site bleeding during laparoscopic surgery.

Uso de la Sonda de Foley para el Control del Sangrado de la Pared Abdominal por los Orificios de los Trócares durante la Cirugía Laparoscópica / Use of Foley’s catheter to control abdominal wall bleeding in the trocar insertion place during laparoscopic surgery

INTRODUCCIÓN: Las hemorragias en los puntos de entrada de los trócares son en ocasiones difíciles de cohibir y se asocian con una morbilidad que oscila desde el dolor parietal y el hematoma, hasta el hemoperitoneo masivo. MATERIAL Y MÉTODOS: Realizamos un estudio retrospectivo de nuestra experiencia en el control de las hemorragias en los puntos de entrada de los trócares de laparoscopia mediante compresión con balón de sonda de Foley, en los que la hemostasia mediante electrocoagulación no fue efectiva. RESULTADOS: La técnica fue empleada en 35 pacientes (27 mujeres y 8 varones) con una edad media de 45,37 años (intervalo 24 - 82 años). La mediana de tiempo hasta la retirada de la sonda fue 36 horas (intervalo 24 - 48 horas), sin evidenciarse ningún tipo de complicación hemorrágica, prolongación de la estancia ni reingreso hospitalario. CONCLUSIONES: La compresión con balón de sonda de Foley es un método sencillo y eficaz para el control de las hemorragias a través de los orificios de los trócares de laparoscopia.

BACKGROUND: Abdominal wall bleeding in the port-site insertion place during laparoscopic surgery is sometimes difficult to control and can be associated with morbidity ranging from parietal pain up to haematoma and massive haemoperitoneum. PATIENTS AND METHODS: We perform a retrospective study of our experience in the management of the abdominal wall bleeding port-site using a Foley’s catheter (24F), in those cases when haemostasis with electrocautery was not achieved. RESULTS: This technique was used in 35 patients (27 women and 8 men) with a mean age of 45,37 years (range 24-82 years). The median of time up to the removal of the catheter was 36 hours (range 24-48 hours), without observing bleeding or prolongation of the hospital stay or readmission. CONCLUSIONS: The use of Foley’s catheter is a simple and efficient method for the control of the port-site bleeding during laparoscopic surgery.

Chyle fistula in right cervical area after thyroid surgery.

Thoracic duct injury is an infrequent (1-2.5%) but severe complication after neck surgery, leading to nutritional, metabolic and immunologic deficiencies. We report a case of a 34-year-old woman with a right thoracic duct injury after surgery of a thyroid medullar cancer effectively treated with conservative management (parenteral nutrition and intravenous somatostatin). Optimal treatment of these patients is unclear, without a clear limit between conservative and surgical treatment.